Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Sagent Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-23.1 - EX-23.1 - Sagent Pharmaceuticals, Inc. | d305285dex231.htm |
| EX-31.2 - EX-31.2 - Sagent Pharmaceuticals, Inc. | d305285dex312.htm |
| EX-21.1 - EX-21.1 - Sagent Pharmaceuticals, Inc. | d305285dex211.htm |
| EX-31.1 - EX-31.1 - Sagent Pharmaceuticals, Inc. | d305285dex311.htm |
| EX-32.1 - EX-32.1 - Sagent Pharmaceuticals, Inc. | d305285dex321.htm |
| 10-K - 10-K - Sagent Pharmaceuticals, Inc. | d305285d10k.htm |
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-175352) pertaining to the 2007 Global Share Plan of Sagent Holding Co. and the 2011 Incentive Compensation Plan of Sagent Pharmaceuticals, Inc. of our report dated March 28, 2012, with respect to the financial statements of Kanghong Sagent (Chengdu) Pharmaceutical Co., Ltd. (a development stage company), included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young Hua Ming
Shanghai, the People’s Republic of China
March 28, 2012